Case Laws
Acts
Notifications
Circulars
Classification
Forms
Manuals
Articles
News
D. Forum
Highlights
Notes
🚨 Important Update for Our Users
We are transitioning to our new and improved portal - www.taxtmi.com - for a better experience.
Home
Forgot password New User/ Regiser ⇒ Register to get Live Demo
Cefadroxil (250 mg) and Potassium Clavulanate (62.5 mg) Dispersible Tablets {each tablet contains cefadroxil monohydrate equivalent to 250 mg Cefadroxil on Anhydrous basis and Clavulanate potassium equivalent to Clavulanic acid 62.5 mg} - Standards of Input Output Norms (SION) - A. Chemical & Allied ProductsExtract A-3653 Cefadroxil (250 mg) and Potassium Clavulanate (62.5 mg) Dispersible Tablets {each tablet contains cefadroxil monohydrate equivalent to 250 mg Cefadroxil on Anhydrous basis and Clavulanate potassium equivalent to Clavulanic acid 62.5 mg} 1000 Tablets 1) Cefadroxil monohydrate 267.622 gm 2) Potassium Clavulanate 75.943 gm ************** NOTES:- 1. Inserted vide Public Notice No. 64 /2015-2020 dated 17-03-2016
|